Articles with public access mandates - James Theiler - Bill & Melinda Gates FoundationLearn more
Available based on mandate: 7
Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus
B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, ...
Cell 182 (4), 812-827. e19, 2020
HIV-1 neutralizing antibody signatures and application to epitope-targeted vaccine design
CA Bricault, K Yusim, MS Seaman, H Yoon, J Theiler, EE Giorgi, K Wagh, ...
Cell host & microbe 25 (1), 59-72. e8, 2019
Defining the risk of SARS-CoV-2 variants on immune protection
MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ...
Nature 605 (7911), 640-652, 2022
Epigraph: a vaccine design tool applied to an HIV therapeutic vaccine and a pan-filovirus vaccine
J Theiler, H Yoon, K Yusim, LJ Picker, K Fruh, B Korber
Scientific reports 6 (1), 1-15, 2016
Characterization of the SARS-CoV-2 B. 1.621 (Mu) variant
PJ Halfmann, M Kuroda, T Armbrust, J Theiler, A Balaram, GK Moreno, ...
Science translational medicine 14 (657), eabm4908, 2022
Graphâbased optimization of epitope coverage for vaccine antigen design
J Theiler, B Korber
Statistics in medicine 37 (2), 181-194, 2018
Antigenicity-defined conformations of an extremely neutralization-resistant HIV-1 envelope spike
Y Cai, S Karaca-Griffin, J Chen, S Tian, N Fredette, CE Linton, ...
Proceedings of the National Academy of Sciences 114 (17), 4477-4482, 2017
Publication and funding information is determined automatically by a computer program